635 related articles for article (PubMed ID: 32061061)
1. Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.
Qin Q; Shi A; Zhang R; Wen Q; Niu T; Chen J; Qiu Q; Wan Y; Sun X; Xing L
Thorac Cancer; 2020 Apr; 11(4):964-972. PubMed ID: 32061061
[TBL] [Abstract][Full Text] [Related]
2. Influence of tumor characteristics on correction differences between cone-beam computed tomography-guided patient setup strategies in stereotactic body radiation therapy for lung cancer.
Jang SS; Park SY; Cho EY; Yang PS; Huh GJ; Yang YJ
Thorac Cancer; 2020 Feb; 11(2):311-319. PubMed ID: 31802637
[TBL] [Abstract][Full Text] [Related]
3. The feasibility of evaluating radiation dose to the heart by integrating kilovoltage-cone beam computed tomography in stereotactic body radiotherapy of early non-small-cell lung cancer patients.
Liu C; Gong G; Guo C; Liu T; Lu J; Zhao H; Dong W; Yin Y
Radiat Oncol; 2013 Dec; 8():295. PubMed ID: 24369788
[TBL] [Abstract][Full Text] [Related]
4. Prediction of SBRT response in liver cancer by combining original and delta cone-beam CT radiomics: a pilot study.
Yang P; Shan J; Ge X; Zhou Q; Ding M; Niu T; Du J
Phys Eng Sci Med; 2024 Mar; 47(1):295-307. PubMed ID: 38165634
[TBL] [Abstract][Full Text] [Related]
5. Impact of feature selection methods and subgroup factors on prognostic analysis with CT-based radiomics in non-small cell lung cancer patients.
Sugai Y; Kadoya N; Tanaka S; Tanabe S; Umeda M; Yamamoto T; Takeda K; Dobashi S; Ohashi H; Takeda K; Jingu K
Radiat Oncol; 2021 Apr; 16(1):80. PubMed ID: 33931085
[TBL] [Abstract][Full Text] [Related]
6. Radiomics-based Assessment of Radiation-induced Lung Injury After Stereotactic Body Radiotherapy.
Moran A; Daly ME; Yip SSF; Yamamoto T
Clin Lung Cancer; 2017 Nov; 18(6):e425-e431. PubMed ID: 28623121
[TBL] [Abstract][Full Text] [Related]
7. A PET/CT radiomics model for predicting distant metastasis in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy: a multicentric study.
Yu L; Zhang Z; Yi H; Wang J; Li J; Wang X; Bai H; Ge H; Zheng X; Ni J; Qi H; Guan Y; Xu W; Zhu Z; Xing L; Dekker A; Wee L; Traverso A; Ye Z; Yuan Z
Radiat Oncol; 2024 Jan; 19(1):10. PubMed ID: 38254106
[TBL] [Abstract][Full Text] [Related]
8. Tumor volume change with stereotactic body radiotherapy (SBRT) for early-stage lung cancer: evaluating the potential for adaptive SBRT.
Bhatt AD; El-Ghamry MN; Dunlap NE; Bhatt G; Harkenrider MM; Schuler JC; Zacarias A; Civelek AC; Pan J; Rai SN; Woo SY
Am J Clin Oncol; 2015 Feb; 38(1):41-6. PubMed ID: 24513663
[TBL] [Abstract][Full Text] [Related]
9. Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images.
van Timmeren JE; Leijenaar RTH; van Elmpt W; Reymen B; Oberije C; Monshouwer R; Bussink J; Brink C; Hansen O; Lambin P
Radiother Oncol; 2017 Jun; 123(3):363-369. PubMed ID: 28506693
[TBL] [Abstract][Full Text] [Related]
10. Accuracy and inter-observer variability of 3D versus 4D cone-beam CT based image-guidance in SBRT for lung tumors.
Sweeney RA; Seubert B; Stark S; Homann V; Müller G; Flentje M; Guckenberger M
Radiat Oncol; 2012 Jun; 7():81. PubMed ID: 22682767
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence.
van Timmeren JE; van Elmpt W; Leijenaar RTH; Reymen B; Monshouwer R; Bussink J; Paelinck L; Bogaert E; De Wagter C; Elhaseen E; Lievens Y; Hansen O; Brink C; Lambin P
Radiother Oncol; 2019 Jul; 136():78-85. PubMed ID: 31015133
[TBL] [Abstract][Full Text] [Related]
12. Feature selection methodology for longitudinal cone-beam CT radiomics.
van Timmeren JE; Leijenaar RTH; van Elmpt W; Reymen B; Lambin P
Acta Oncol; 2017 Nov; 56(11):1537-1543. PubMed ID: 28826307
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of interfractional variation of the centroid position and volume of internal target volume during stereotactic body radiotherapy of lung cancer using cone-beam computed tomography.
Sun Y; Ge H; Cheng S; Yang C; Zhu Q; Li D; Tian Y
J Appl Clin Med Phys; 2016 Mar; 17(2):461-472. PubMed ID: 27074466
[TBL] [Abstract][Full Text] [Related]
14. Cone-beam computed tomography-based delta-radiomics for early response assessment in radiotherapy for locally advanced lung cancer.
Shi L; Rong Y; Daly M; Dyer B; Benedict S; Qiu J; Yamamoto T
Phys Med Biol; 2020 Jan; 65(1):015009. PubMed ID: 31307024
[TBL] [Abstract][Full Text] [Related]
15. Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.
Pyka T; Bundschuh RA; Andratschke N; Mayer B; Specht HM; Papp L; Zsótér N; Essler M
Radiat Oncol; 2015 Apr; 10():100. PubMed ID: 25900186
[TBL] [Abstract][Full Text] [Related]
16. Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance.
Sonke JJ; Rossi M; Wolthaus J; van Herk M; Damen E; Belderbos J
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):567-74. PubMed ID: 19046825
[TBL] [Abstract][Full Text] [Related]
17. Low-dose hilar and mediastinal stereotactic body radiation therapy for non-small cell lung cancer: Analysis of outcomes in patients receiving one or multiple courses of treatment.
Kowalchuk RO; Waters MR; Richardson M; Spencer K; Larner JM; Kersh CR
Thorac Cancer; 2020 Jul; 11(7):2005-2013. PubMed ID: 32469465
[TBL] [Abstract][Full Text] [Related]
18. Quantifying interfraction and intrafraction tumor motion in lung stereotactic body radiotherapy using respiration-correlated cone beam computed tomography.
Bissonnette JP; Franks KN; Purdie TG; Moseley DJ; Sonke JJ; Jaffray DA; Dawson LA; Bezjak A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):688-95. PubMed ID: 19395200
[TBL] [Abstract][Full Text] [Related]
19. Radiomics for prediction of radiation-induced lung injury and oncologic outcome after robotic stereotactic body radiotherapy of lung cancer: results from two independent institutions.
Bousabarah K; Blanck O; Temming S; Wilhelm ML; Hoevels M; Baus WW; Ruess D; Visser-Vandewalle V; Ruge MI; Treuer H; Kocher M
Radiat Oncol; 2021 Apr; 16(1):74. PubMed ID: 33863358
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system.
Katoh N; Soda I; Tamamura H; Takahashi S; Uchinami Y; Ishiyama H; Ota K; Inoue T; Onimaru R; Shibuya K; Hayakawa K; Shirato H
Radiat Oncol; 2017 Jan; 12(1):3. PubMed ID: 28057036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
